FDA.reportPublic FDA data

EPLERENONE

Substance profile for UNII 6995V82D0B, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for EPLERENONE
Structure render from PubChem CID 443872

Substance Identity#

UNII
6995V82D0B
Preferred term
EPLERENONE
Registry number
107724-20-9
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C24H30O6
Chemical structure for EPLERENONE
Structure render from PubChem CID 443872

Chemical And Database Identifiers#

InChIKey
JUKPWJGBANNWMW-VWBFHTRKSA-N
SMILES
COC(=O)[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@@]34O[C@@H]3C[C@@]5(C)[C@@H](CC[C@@]56CCC(=O)O6)[C@H]14
RxCUI
298869
PubChem
443872
NCIt
C47513
INN ID
7596

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound443872https://pubchem.ncbi.nlm.nih.gov/compound/443872
PubChem InChIKey SearchJUKPWJGBANNWMW-VWBFHTRKSA-Nhttps://pubchem.ncbi.nlm.nih.gov/#query=JUKPWJGBANNWMW-VWBFHTRKSA-N
RxNorm298869https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=298869
NCI ThesaurusC47513https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C47513
FDA Substance Registration System6995V82D0Bhttps://precision.fda.gov/uniisearch/srs/unii/6995V82D0B

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
EPLERENONEACTIVE INGREDIENT6995V82D0BThese highlights do not include all the information needed to use Eplerenone Tablets safely and effectively. See full prescribing information for Eplerenone Tablets. Initial U.S. Approval: 20022
EPLERENONEACTIVE MOIETY6995V82D0BThese highlights do not include all the information needed to use Eplerenone Tablets safely and effectively. See full prescribing information for Eplerenone Tablets. Initial U.S. Approval: 20022
EPLERENONEACTIVE INGREDIENT6995V82D0BThese highlights do not include all the information needed to use Eplerenone Tablets safely and effectively. See full prescribing information for Eplerenone Tablets. Initial U.S. Approval: 20021
EPLERENONEACTIVE MOIETY6995V82D0BThese highlights do not include all the information needed to use Eplerenone Tablets safely and effectively. See full prescribing information for Eplerenone Tablets. Initial U.S. Approval: 20021
eplerenoneACTIVE INGREDIENT6995V82D0BThese highlights do not include all the information needed to use INSPRA safely and effectively. See full prescribing information for INSPRA. INSPRA (eplerenone) tablet for oral use Initial U.S. Approval: 20021
eplerenoneACTIVE MOIETY6995V82D0BThese highlights do not include all the information needed to use INSPRA safely and effectively. See full prescribing information for INSPRA. INSPRA (eplerenone) tablet for oral use Initial U.S. Approval: 20021
EPLERENONEACTIVE MOIETY6995V82D0BEPLERENONE TABLET [EON LABS, INC.]13
EPLERENONEACTIVE INGREDIENT6995V82D0BEPLERENONE TABLET [EON LABS, INC.]13
EPLERENONEACTIVE MOIETY6995V82D0BEPLERENONE TABLET [UPSHER-SMITH LABORATORIES, INC.]10
EPLERENONEACTIVE INGREDIENT6995V82D0BEPLERENONE TABLET [UPSHER-SMITH LABORATORIES, INC.]10
EPLERENONEACTIVE MOIETY6995V82D0BEPLERENONE TABLET, FILM COATED [GREENSTONE LLC]10
EPLERENONEACTIVE INGREDIENT6995V82D0BEPLERENONE TABLET, FILM COATED [GREENSTONE LLC]10
EPLERENONEACTIVE MOIETY6995V82D0BINSPRA (EPLERENONE) TABLET, FILM COATED [G.D. SEARLE LLC DIVISION OF PFIZER INC]10
EPLERENONEACTIVE INGREDIENT6995V82D0BINSPRA (EPLERENONE) TABLET, FILM COATED [G.D. SEARLE LLC DIVISION OF PFIZER INC]10
EPLERENONEACTIVE MOIETY6995V82D0BEPLERENONE (EPLERENONE ) TABLET [APOTEX CORP]2
EPLERENONEACTIVE INGREDIENT6995V82D0BEPLERENONE (EPLERENONE ) TABLET [APOTEX CORP]2
EPLERENONEACTIVE INGREDIENT6995V82D0BEPLERENONE TABLET [AMERICAN HEALTH PACKAGING]1
EPLERENONEACTIVE MOIETY6995V82D0BEPLERENONE TABLET [AMERICAN HEALTH PACKAGING]1